• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


10.9000 USD 0.3100 2.77%

As of 20:10:00 ET on 07/24/2014.

Snapshot for uniQure B.V. (QURE)

Open: 11.2100 Day's Range: 10.8700 - 11.2675 Volume: 17,060
Previous Close: 11.2100 52wk Range: 8.2900 - 18.7500 1-Yr Rtn: -

Stock Chart for QURE

No chart data available.
  • QURE:US 10.9000
  • 1D
  • 1M
  • 1Y
Interactive QURE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QURE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (EUr) (ttm) -
Est. EPS (EUr) (12/2014) -160.9590
Est. PEG Ratio -
Market Cap (M USD) 191.78
Shares Outstanding (M) 17.59
30 Day Average Volume 54,062
Price/Book (mrq) 59.0402
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QURE

No data available

Company Profile & Key Executives for QURE

UNIQURE B.V. develops gene therapy products that offer the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.

Jorn AldagCEO/Member-Mgmt BoardEric GoossensChief Operating Officer
Hans PreustingChief Business OfficerHans Christian RohdeChief Commercial Officer
More Company Profile & Key Executives for QURE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil